Edition:
United Kingdom

Eleven Biotherapeutics Inc (EBIO.OQ)

EBIO.OQ on NASDAQ Stock Exchange Global Market

0.66USD
12 Dec 2017
Change (% chg)

$-0.03 (-4.26%)
Prev Close
$0.69
Open
$0.69
Day's High
$0.69
Day's Low
$0.64
Volume
167,043
Avg. Vol
102,819
52-wk High
$2.53
52-wk Low
$0.63

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -0.369
Jun '17 0.00 -0.296
Mar '17 0.43 -0.246
FY 2016 Dec '16 0.82 -0.145
Sep '16 28.65 0.910
Jun '16 0.28 -0.327
Mar '16 0.23 -0.386
FY 2015 Dec '15 0.56 -0.528
Sep '15 0.07 -0.501
Jun '15 0.11 -0.362
Mar '15 0.24 -0.363
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 6.84 88.65 32.93
P/E High - Last 5 Yrs. 21.95 290.75 45.62
P/E Low - Last 5 Yrs. 21.95 93.66 24.34
Beta 3.54 0.85 0.88
Price to Sales (TTM) 1.26 100.67 5.40
Price to Book (MRQ) 1.45 13.50 5.38
Price to Tangible Book (MRQ) -- 13.43 6.78
Price to Cash Flow (TTM) 13.23 76.23 23.45
% Owned Institutions 31.95 6.25 1.40

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.50
Dividend Yield - 5 Year Avg -- 0.28 1.52
Dividend 5 Year Growth Rate -- 1.88 5.17
Payout Ratio(TTM) 0.00 17.26 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -100.00 433.84 9.00
Sales (TTM) vs TTM 1 Yr. Ago 2,527.42 75.03 5.38
Sales - 5 Yr. Growth Rate -- 33.47 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago 9.26 30.81 19.67
EPS (TTM) vs TTM 1 Yr. Ago 112.76 -- --
EPS - 5 Yr. Growth Rate -- 43.17 10.79
Capital Spending - 5 Yr. Growth Rate -- 40.71 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.68 2.18
Current Ratio (MRQ) 4.27 5.36 2.98
LT Debt to Equity (MRQ) 0.00 18.92 11.56
Total Debt to Equity (MRQ) 0.00 20.59 15.81
Interest Coverage (TTM) -29.93 -112.49 33.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 38.73 54.83
Gross Margin - 5 Yr. Avg. -- 51.18 52.40
EBITD Margin (TTM) 8.88 -- --
EBITD - 5 Yr. Avg -286.84 -261.11 15.24
Operating Margin (TTM) 11.07 -556.64 7.76
Operating Margin - 5 Yr. Avg. -292.97 -279.29 10.75
Pre-Tax Margin (TTM) 8.64 -529.88 8.57
Pre-Tax Margin - 5 Yr. Avg. -299.28 -279.02 11.17
Net Profit Margin (TTM) 8.63 -531.33 4.88
Net Profit Margin - 5 Yr. Avg. -299.29 -282.20 7.47
Effective Tax Rate (TTM) 0.19 23.72 23.11
Effective Tax Rate - 5 Yr. Avg. -- 19.13 24.00

Efficiency

  Company industry sector
Revenue/Employee (TTM) 879,412 25,314,503 864,673,366
Net Income/Employee (TTM) 75,853 3,332,048 101,717,513
Receivable Turnover (TTM) -- 21.54 5.76
Inventory Turnover (TTM) -- 2.01 3.34
Asset Turnover (TTM) 0.57 0.37 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 4.94 -0.78 11.00
Return on Assets - 5 Yr. Avg. -62.31 -0.26 12.43
Return on Investment (TTM) 5.29 2.35 14.46
Return on Investment - 5 Yr. Avg. -72.36 2.98 16.28
Return on Equity (TTM) 16.08 2.95 16.05
Return on Equity - 5 Yr. Avg. -- 6.40 17.51
  1 Year 3 Year 5 Year
Sales % 2,928.38 182.20 --
EPS (TTM) % 104.94 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Eleven Biotherapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 34.15%
# of Holders: 33
Total Shares Held: 10,872,043
3 Mo. Net Change: 2,983,687
# New Positions: 6
# Closed Positions: 7
# Increased Positions: 7
# Reduced Positions: 14
# Net Buyers: -7
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.